KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) Operating Expenses (2016 - 2026)

Insulet filings provide 16 years of Operating Expenses readings, the most recent being $422.3 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 31.35% to $422.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 28.96% increase, with the full-year FY2025 number at $1.5 billion, up 28.97% from a year prior.
  • Operating Expenses hit $422.3 million in Q4 2025 for Insulet, up from $392.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $422.3 million in Q4 2025 to a low of $37.5 million in Q3 2021.
  • Median Operating Expenses over the past 5 years was $236.2 million (2023), compared with a mean of $223.5 million.
  • Biggest five-year swings in Operating Expenses: decreased 3.35% in 2021 and later surged 441.15% in 2022.
  • Insulet's Operating Expenses stood at $41.8 million in 2021, then skyrocketed by 363.64% to $193.8 million in 2022, then skyrocketed by 31.42% to $254.7 million in 2023, then rose by 26.23% to $321.5 million in 2024, then skyrocketed by 31.35% to $422.3 million in 2025.
  • The last three reported values for Operating Expenses were $422.3 million (Q4 2025), $392.4 million (Q3 2025), and $331.1 million (Q2 2025) per Business Quant data.